Hydrocarbon chain derivative 1
Hydrocarbon chain derivative 1 is an active compound, with inhibitory activities against lipid synthesis.
For research use only. We do not sell to patients.
- CAS No.: 300762-25-8
- Formula: C16H34O3
- Molecular Weight:274.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Hepatocyte | IC50 |
10.7 μM
Compound: 38
|
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
|
[PMID: 16392818] |
| Hepatocyte | IC50 |
11 μM
Compound: 28
|
In vitro inhibitory concentration against lipid synthesis in primary rat hepatocyte culture
In vitro inhibitory concentration against lipid synthesis in primary rat hepatocyte culture
|
[PMID: 15456261] |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 300762-25-8
-
Molecular Weight 274.44
-
Formula C16H34O3
-
SMILES
OCC(C)(C)CCCCOCCCCC(C)(C)CO
-
Synonyms
6,6'-Oxybis[2,2-dimethyl-1-hexanol]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Oniciu DC, et al. Influence of various central moieties on the hypolipidemic properties of long hydrocarbon chain diols and diacids. J Med Chem. 2006 Jan 12;49(1):334-48. [Content Brief]
[2]. Oniciu DC, et al. Long hydrocarbon chain diols and diacids with central ether or ketone moieties that favorably alter lipid disorders. Pharmazie. 2006 Feb;61(2):157-65. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)